PL378247A1 - Pde4 inhibitors for the treatment of neoplasms of lymphoid cells - Google Patents
Pde4 inhibitors for the treatment of neoplasms of lymphoid cellsInfo
- Publication number
- PL378247A1 PL378247A1 PL378247A PL37824704A PL378247A1 PL 378247 A1 PL378247 A1 PL 378247A1 PL 378247 A PL378247 A PL 378247A PL 37824704 A PL37824704 A PL 37824704A PL 378247 A1 PL378247 A1 PL 378247A1
- Authority
- PL
- Poland
- Prior art keywords
- neoplasms
- treatment
- lymphoid cells
- pde4 inhibitors
- pde4
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/502—Pyridazines; Hydrogenated pyridazines ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03000787 | 2003-01-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
PL378247A1 true PL378247A1 (en) | 2006-03-20 |
Family
ID=32695591
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL378247A PL378247A1 (en) | 2003-01-14 | 2004-01-14 | Pde4 inhibitors for the treatment of neoplasms of lymphoid cells |
Country Status (10)
Country | Link |
---|---|
US (1) | US20060148804A1 (en) |
EP (1) | EP1587512A2 (en) |
JP (1) | JP2006515367A (en) |
AU (1) | AU2004204355B2 (en) |
CA (1) | CA2512819A1 (en) |
HR (1) | HRP20050699A2 (en) |
IS (1) | IS7970A (en) |
PL (1) | PL378247A1 (en) |
RS (1) | RS20050523A (en) |
WO (1) | WO2004062671A2 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR049384A1 (en) | 2004-05-24 | 2006-07-26 | Glaxo Group Ltd | PURINA DERIVATIVES |
GB0514809D0 (en) | 2005-07-19 | 2005-08-24 | Glaxo Group Ltd | Compounds |
WO2009011897A1 (en) * | 2007-07-17 | 2009-01-22 | Combinatorx, Incorporated | Combinations for the treatment of b-cell proliferative disorders |
CA2694983A1 (en) * | 2007-07-17 | 2009-01-22 | Combinatorx, Incorporated | Treatments of b-cell proliferative disorders |
WO2009147169A1 (en) * | 2008-06-03 | 2009-12-10 | Universite Paris Diderot-Paris 7 | Pharmaceuticl compositions useful for the treatment of cancers, in particular acute myeloid leukemia and acute promyelocytic leukemia |
WO2009151569A2 (en) * | 2008-06-09 | 2009-12-17 | Combinatorx, Incorporated | Beta adrenergic receptor agonists for the treatment of b-cell proliferative disorders |
CN103582644B (en) * | 2011-06-17 | 2016-07-20 | 塔科达有限责任公司 | Phthalazone-pyrrolopyrimidine carboxamide derivative |
AR089232A1 (en) * | 2011-12-16 | 2014-08-06 | Chiesi Farma Spa | POTENTIAL INDUCED BY PDE4 INHIBITORS IN THE TREATMENT OF LEUKEMIA |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6399649B1 (en) * | 1998-09-24 | 2002-06-04 | Boston Medical Center Corporation | Compositions and methods for the treatment of chronic lymphocytic leukemia |
US6624154B1 (en) * | 1999-04-23 | 2003-09-23 | Bristol-Myers Squibb Company | Compositions and methods for treatment of hyperproliferative diseases |
US6232121B1 (en) * | 1999-06-03 | 2001-05-15 | Hugh S. Keeping | Methods for the production of biologically active agents contained in an extracellular matrix |
AU5195599A (en) * | 1999-08-10 | 2001-03-13 | Wago Co., Ltd. | Anchor bolt and method of manufacturing the anchor bolt |
JP5038568B2 (en) * | 1999-08-21 | 2012-10-03 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | Combination of synergists |
IL148807A0 (en) * | 1999-10-25 | 2002-09-12 | Byk Gulden Lomberg Chem Fab | Tetrahydrothiopyran derivatives and pharmaceutical compositions containing the same |
JP2003535148A (en) * | 2000-06-06 | 2003-11-25 | グラクソ グループ リミテッド | How to treat cancer |
EA200300836A1 (en) * | 2001-02-15 | 2004-02-26 | Алтана Фарма Аг | DERIVATIVES OF PHTHALASINON-PIPERIDINE AS PDE4 INHIBITORS |
GB0111497D0 (en) * | 2001-05-11 | 2001-07-04 | Medical Res Council | Therapeutic methods |
-
2004
- 2004-01-14 CA CA002512819A patent/CA2512819A1/en not_active Abandoned
- 2004-01-14 JP JP2006500561A patent/JP2006515367A/en active Pending
- 2004-01-14 AU AU2004204355A patent/AU2004204355B2/en not_active Ceased
- 2004-01-14 EP EP04701902A patent/EP1587512A2/en not_active Withdrawn
- 2004-01-14 RS YUP-2005/0523A patent/RS20050523A/en unknown
- 2004-01-14 PL PL378247A patent/PL378247A1/en not_active Application Discontinuation
- 2004-01-14 US US10/542,088 patent/US20060148804A1/en not_active Abandoned
- 2004-01-14 WO PCT/EP2004/000196 patent/WO2004062671A2/en active Application Filing
-
2005
- 2005-08-03 HR HR20050699A patent/HRP20050699A2/en not_active Application Discontinuation
- 2005-08-05 IS IS7970A patent/IS7970A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2004062671A3 (en) | 2005-01-27 |
RS20050523A (en) | 2007-09-21 |
CA2512819A1 (en) | 2004-07-29 |
HRP20050699A2 (en) | 2006-11-30 |
AU2004204355B2 (en) | 2009-12-17 |
US20060148804A1 (en) | 2006-07-06 |
JP2006515367A (en) | 2006-05-25 |
WO2004062671A2 (en) | 2004-07-29 |
IS7970A (en) | 2005-08-05 |
EP1587512A2 (en) | 2005-10-26 |
AU2004204355A1 (en) | 2004-07-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL174232A0 (en) | Combinations of drugs for the treatment of neoplasms | |
AU2003249244A1 (en) | Methods for the treatment of neoplasms | |
ZA200500618B (en) | Combinations of drugs for the treatment of neoplasms | |
PL373146A1 (en) | Pyridazinone-derivatives as pde4 inhibitors | |
EP1804794A4 (en) | Spiropiperidine compounds useful as beta-secretase inhibitors for the treatment of alzhermer s disease | |
IL174014A0 (en) | Methods for the treatment of endometriosis | |
IL176028A0 (en) | Compounds for treatment of cell proliferative diseases | |
EP1635813A4 (en) | Combination therapy for the treatment of dyslipidemia | |
EP1664051A4 (en) | Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders | |
GB2415378B (en) | Treatment of neurodegenerative conditions | |
GB2422373B (en) | Treatment of neurodegenerative conditions | |
GB0329874D0 (en) | Compounds useful for the treatment of diseases | |
EP1651211A4 (en) | Combination of drugs for the treatment of neoplasms | |
IS7970A (en) | PDE4 inhibitors for the treatment of lymphoma | |
AU2003251875A8 (en) | Combination therapy for the treatment of neoplasms | |
AU2003251904A8 (en) | Combinations of drugs for the treatment of neoplasms | |
HK1097247A1 (en) | Process for the treatment of sludge | |
GB0424663D0 (en) | Sludge treatment | |
GB0300783D0 (en) | Treatment of neurodegenerative conditions | |
GB2422600B (en) | Sludge treatment | |
GB0323078D0 (en) | Sewage treatment | |
GB0327975D0 (en) | Methods of treatment | |
ZA200600494B (en) | Reduction of the concentration of undesired compounds | |
GB0300793D0 (en) | Treatment of chemical waste | |
GB0322921D0 (en) | Methods of treatment |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |